Wout van Aert Misses Tour de France Due to Sepsis Scare

Wout van Aert will miss the Tour de France after being hospitalized to prevent blood poisoning following a lingering elbow injury, according to reports from VRT and Sporza on June 18, 2026. The cyclist narrowly avoided sepsis, a life-threatening systemic response to infection, during a medical crisis described as “extremely serious.”

The Belgian rider’s absence comes as a significant blow to his team’s strategy. According to WielerFlits, van Aert has been the most frequently selected rider for Visma in the Tour de France since making his debut.

The medical emergency stemmed from a persistent injury to his elbow. VRT reported that the injury lingered, eventually leading to a complication that required urgent hospital intervention to stop the onset of blood poisoning.

Sporza characterized the medical situation as critical, noting that hospitalization was necessary to prevent the infection from spreading into the bloodstream.

Why did a lingering injury lead to sepsis?

Sepsis occurs when the body’s response to an infection damages its own tissues. In this case, an elbow injury provided the entry point for an infection that threatened to become systemic. HLN reports that the condition is highly dangerous and cited the death of actress Daveigh Chase as an example of the severity of sepsis.

Van Aert’s situation reached a point where immediate medical action was the only way to avoid full-scale sepsis. The timing of the treatment proved decisive in his recovery.

“The first three hours are crucial”

Wout van Aert via Nieuwsblad

Nieuwsblad reported that van Aert narrowly escaped the worst possible outcome because of this rapid response. The rider emphasized that the initial window of treatment is the most critical factor in surviving or preventing the progression of blood poisoning.

How does this affect Team Visma’s Tour de France roster?

Van Aert’s absence removes one of the most versatile assets from the Visma squad. His track record as the team’s most consistent selection for the race underscores his role as both a sprinter and a support rider for the general classification contenders.

While the team hasn’t officially named a replacement, the loss of a rider with van Aert’s specific skill set forces a tactical shift. He typically handles multiple roles, from winning flat stages to protecting the team leader in the mountains.

What is the medical outlook for Wout van Aert?

The immediate focus for van Aert is recovery and ensuring the infection is fully eradicated. Because the situation was “extremely serious,” as reported by Sporza, the recovery process will likely be slow and monitored closely by medical staff.

The transition from a localized elbow injury to a systemic threat highlights the risks associated with untreated or lingering infections in professional athletes, whose bodies are often under extreme physical stress. Medical professionals cited in the HLN report note that recognizing symptoms early is the only way to prevent the rapid descent into sepsis.

Van Aert’s narrow escape means he’ll spend the duration of the Tour de France in rehabilitation rather than competition. There’s no current timeline for his return to professional racing.